Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Abstract Text:

Milan Fiala,Philip T Liu,Araceli Espinosa-Jeffrey,Mark J Rosenthal,George Bernard,John M Ringman,James Sayre,Laura Zhang,Justin Zaghi,Sheila Dejbakhsh,Ben Chiang,James Hui,Michelle Mahanian,Anita Baghaee,Pamela Hong,John Cashman,

We have tested a hypothesis that the natural product curcuminoids, which has epidemiologic and experimental rationale for use in AD, may improve the innate immune system and increase amyloid-beta (Abeta) clearance from the brain of patients with sporadic Alzheimer's disease (AD). Macrophages of a majority of AD patients do not transport Abeta into endosomes and lysosomes, and AD monocytes do not efficiently clear Abeta from the sections of AD brain, although they phagocytize bacteria. In contrast, macrophages of normal subjects transport Abeta to endosomes and lysosomes, and monocytes of these subjects clear Abeta in AD brain sections. Upon Abeta stimulation, mononuclear cells of normal subjects up-regulate the transcription of beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (MGAT3) (P < 0.001) and other genes, including Toll like receptors (TLRs), whereas mononuclear cells of AD patients generally down-regulate these genes. Defective phagocytosis of Abeta may be related to down-regulation of MGAT3, as suggested by inhibition of phagocytosis by using MGAT3 siRNA and correlation analysis. Transcription of TLR3, bditTLR4, TLR5, bditTLR7, TLR8, TLR9, and TLR10 upon Abeta stimulation is severely depressed in mononuclear cells of AD patients in comparison to those of control subjects. In mononuclear cells of some AD patients, the curcuminoid compound bisdemethoxycurcumin may enhance defective phagocytosis of Abeta, the transcription of MGAT3 and TLRs, and the translation of TLR2-4. Thus, bisdemethoxycurcumin may correct immune defects of AD patients and provide a previously uncharacterized approach to AD immunotherapy.

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Publishing Authors By Initials

M Fiala,PT Liu,A Espinosa-Jeffrey,MJ Rosenthal,G Bernard,JM Ringman,J Sayre,L Zhang,J Zaghi,S Dejbakhsh,B Chiang,J Hui,M Mahanian,A Baghaee,P Hong,J Cashman,

For similar genetic processes: gene expression: transcription, genetic research abstracts see: genetic processes: gene expression: transcription, genetic research

PUBMED ID PMID:

MEDLINE DATE:

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Proceedings of the National Academy of Sciences of

VOLUME: 104

Page Numbers: 12849-54

Journal Abbreviation: Proc. Natl. Acad. Sci. U.S.A.

ISSN: 0027-8424

DAY: 24

MONTH: 07

YEAR: 2007

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7505876

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Keywords Mesh Terms:

KEYWORDS: Transcription, Genetic

MESH TERMS: genetics

Chemical & Substance for Abstract: Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Information

Substance Name: 2-acylglycerol O-acyltransferase

Registry Number: EC 2.3.1.22

Grant and Affiliation Information for Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

AFFILIATION: Department of Medicine, Greater Los Angeles Veterans Affairs Medical Center, and School of Medicine, University of California-Los Angeles, CA 90095, USA. fiala@mednet.ucla.edu

Country: United States

AGENCY: United States NIAID

GRANT: 2T32 AI 07323

ACRONYM: AI

MEDLINETA: Proc Natl Acad Sci U S A

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin Related Publications

• "Herbal" medicines and rheumatoid arthritis.
• Allergy to iprindole (Prondole) with hepatotoxicity.
• Altered bone metabolism in inflammatory disease: role for nutrition.
• Ambulatory electrocardiographic records in patients with transient cerebral attacks or palpitation.
• Ambulatory electrocardiography in car workers.
• Blood glucose variations and clinical experience with glibenclamide in diabetes mellitus.
• Blood glucose variations and clinical experience with glibenclamide in diabetes mellitus.
• Conjugated linoleic acid alters global gene expression in human intestinal-like Caco-2 cells in an isomer-specific manner.
• Damage to the superior gluteal nerve after the Hardinge approach to the hip.
• Development of a brief questionnaire to identify families in need of legal advocacy to improve child health.
• Diagnosis of multiple pregnancy.
• Diet, nutrition, and bone health.
• Early immunization against whooping-cough.
• Ethical Obligations and Concerns When Trying to Achieve a Patient's Wishes: Ethics Consultation.
• Flavin-containing monooxygenase 3 and human disease.
• Functional activity of the mouse flavin-containing monooxygenase forms 1, 3, and 5.
• Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.
• Interprofessional prevention education changing the future of health professions education.
• Investigation of structure and function of a catalytically efficient variant of the human flavin-containing monooxygenase form 3.
• Ionising radiation and the orthopaedic surgeon.
• Methods of improving the accuracy of ambulatory BP and EKG recordings.
• Monoplegia and Horner's syndrome from pressure palsy. Report of a case and anatomical discussion.
• Psychiatric aspects of acute porphyria.
• Seasonal changes in vitamin D status and bone turnover in healthy Irish postmenopausal women.
• Species barriers for chronic wasting disease by in vitro conversion of prion protein.
• Synthesis and Biological Evaluation of alpha- and beta-6-Amido Derivatives of 17-Cyclopropylmethyl-3, 14beta-dihydroxy-4, 5alpha-epoxymorphinan: Potential Alcohol-Cessation Agents.
• Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture.
• Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.
• The relationship between nutrient intake and cognitive performance in people at risk of dementia.
• Vitamin D status and its determinants in adolescents from the Northern Ireland Young Hearts 2000 cohort.